Infectious diseases specialists diagnose and treat infections from bacteria, viruses, fungi, and parasites, focusing on fevers, antibiotics, and vaccines.
Send us all your questions or requests, and our expert team will assist you.
Whooping cough, or pertussis, is a highly contagious respiratory infection caused by the bacterium Bordetella pertussis. Although some people think of it as just a childhood illness, it can seriously damage the lining of the human respiratory tract. This bacterium only infects humans and does not have an animal reservoir, so it spreads entirely from person to person. While it is difficult to grow in the lab, it is very good at infecting people.
Pertussis develops when the bacteria attach to the ciliated cells lining the nose, throat, and airways. Unlike some bacteria that enter the bloodstream, Bordetella pertussis mostly stays on the surface. It uses special proteins, like filamentous hemagglutinin (FHA) and pertactin, to stick to these cells. Once attached to the cilia, which are tiny hairs that help clear mucus from the lungs, the bacteria multiply and release powerful toxins.
The main toxin produced by Bordetella pertussis is called pertussis toxin (PT). This protein enters human cells and disrupts normal cell signaling, especially by interfering with the G-protein complex. As a result, there is too much cyclic adenosine monophosphate (cAMP) inside the cells. This causes problems throughout the body, such as blocking immune cells from reaching the infection and causing a high white blood cell count (lymphocytosis). Because of these effects, pertussis is more than just a local infection—it is a disease driven by toxins that weaken the lungs’ defenses and affect the whole immune system.
To understand the clinical devastation of whooping cough, one must appreciate the mucociliary escalator. In a healthy respiratory tract, the cilia beat in a coordinated, rhythmic fashion to sweep mucus—which traps dust, bacteria, and viruses—upward toward the throat, where it can be swallowed or coughed out. This is the lung’s primary mechanism for maintaining hygiene.
Bordetella pertussis releases a specific substance known as Tracheal Cytotoxin (TCT). TCT is a fragment of the bacterial cell wall peptidoglycan. In the context of pertussis infection, TCT acts as a direct poison to the ciliated cells. It induces nitric oxide production, which damages epithelial cell mitochondria, leading to ciliary stasis (paralysis) and, eventually, the extrusion (death and shedding) of ciliated cells from the airway lining.
This damage to the airway cells explains the symptoms of whooping cough. When the mucociliary escalator is destroyed, the patient cannot clear mucus from the lungs. Thick mucus builds up, blocking airflow and making it easier for other bacteria to cause infections. The severe, repeated coughing is the body’s way of trying to clear this mucus without working cilia. Recovery depends on the regrowth of the ciliated lining, which can take weeks or months. This slow healing is why pertussis is often called the hundred-day cough.
Although the classic symptoms of whooping cough are well known, doctors recognize different forms of the disease depending on a person’s age and immune system. The well-known “whoop” sound is not always present.
Despite widespread vaccination programs, pertussis remains poorly controlled globally. In the modern era, epidemiology has shifted. Historically considered a disease of childhood, surveillance data now indicate a significant burden of disease in adolescents and adults. This resurgence is attributed to several factors, including the waning immunity provided by acellular vaccines compared to the older whole-cell vaccines, and the pathogen’s genetic evolution (antigenic drift) to evade current vaccine-induced antibodies.
The disease exhibits a cyclical pattern, with outbreaks occurring every three to five years. In developing nations, pertussis remains a leading cause of infant mortality. In developed countries with high vaccination coverage, it persists as a cause of chronic respiratory morbidity and a significant public health cost. The modern epidemiological definition of pertussis recognizes it as a re-emerging infectious disease, challenging the notion that vaccination alone, without booster strategies and maintenance of herd immunity, is sufficient for control.
The compromised respiratory tract during a pertussis infection creates a window of opportunity for other pathogens. The destruction of the ciliated epithelium exposes the basement membrane, leaving the lungs vulnerable. Co-infections with viral agents such as Respiratory Syncytial Virus (RSV) and Influenza, or bacterial superinfections with Streptococcus pneumoniae or Staphylococcus aureus, are common complications.
These superinfections often define the mortality risk associated with the disease. A patient may survive the initial toxin-mediated phase of pertussis only to succumb to a secondary bacterial pneumonia. Therefore, the medical definition of a pertussis case often involves evaluating the patient for polymicrobial infection. Understanding this synergy between Bordetella pertussis and other respiratory pathogens is crucial for the comprehensive management of severe cases in intensive care settings.
Send us all your questions or requests, and our expert team will assist you.
The term 100-day cough is a colloquial term for pertussis, referring to the unusually long duration of the illness. Because the bacteria destroy the cilia (tiny hairs) in the lungs, the body cannot clear mucus effectively. The cough persists for weeks or months until the respiratory lining fully regenerates and the cilia grow back, a biological process that is naturally slow.
Yes, pertussis is caused by the bacterium Bordetella pertussis. It is not a viral infection like the flu or the common cold. However, the bacteria produce toxins that have systemic effects on the body, making it act differently than a simple bacterial infection like strep throat. Because it is bacterial, it can be treated with antibiotics in the early stages.
The name comes from the high-pitched sound made when a person gasps for air after a long, violent fit of coughing. This forces air through a narrowed, swollen airway. However, adults, adolescents, and very young infants often do not make this sound. Infants may stop breathing (apnea), while adults may have a dry, nagging cough.
Yes, it is possible. Immunity from the pertussis vaccine is not lifelong; it wanes or fades over time, typically within 5 to 10 years after the last shot. This is why “breakthrough” infections occur in vaccinated adolescents and adults. However, the illness is usually much milder and less likely to cause severe complications in vaccinated individuals.
Toxins are the primary cause of the symptoms. The bacteria attach to the throat and release toxins that damage tissues, trigger inflammation, and impair the immune system’s ability to fight back. One specific toxin, tracheal cytotoxin, paralyzes and kills the cells that sweep mucus from the lungs, leading to severe fluid accumulation and a violent cough.
Leave your phone number and our medical team will call you back to discuss your healthcare needs and answer all your questions.
Your Comparison List (you must select at least 2 packages)
